share_log

This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

這位高盛分析師看好;以下是週一的五大升級推薦
Benzinga ·  12/02 21:47

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖,請參閱我們的分析師評級頁面。

  • Morgan Stanley analyst Drew Ranieri upgraded the rating for Stryker Corporation (NYSE:SYK) from Equal-Weight to Overweight and raised the price target from $370 to $445. Stryker shares closed at $392.15 on Friday. See how other analysts view this stock.
  • Oppenheimer analyst Timothy Horan upgraded Akamai Technologies, Inc. (NASDAQ:AKAM) from Perform to Outperform and announced a $120 price target. Akamai Techs shares closed at $94.02 on Friday. See how other analysts view this stock.
  • JP Morgan analyst Matthew Boss upgraded the rating for The Gap, Inc. (NYSE:GAP) from Neutral to Overweight and boosted the price target from $28 to $30. Gap shares closed at $24.25 on Friday. See how other analysts view this stock.
  • Evercore ISI Group analyst Vijay Kumar upgraded NovoCure Limited (NASDAQ:NVCR) from In-Line to Outperform and raised the price target from $18 to $30. NovoCure shares closed at $20.04 on Friday. See how other analysts view this stock.
  • TD Cowen analyst Bryan Bergin upgraded the rating for Paycor HCM, Inc. (NASDAQ:PYCR) from Hold to Buy and increased the price target from $18 to $22. Paycor HCM shares closed at $18.06 on Tuesday. See how other analysts view this stock.
  • 摩根士丹利分析師Drew Ranieri將斯特賴克公司(紐交所:SYK)的評級從平權升級至超重,將價格目標從$370上調至$445。斯特賴克股票週五收盤價爲$392.15。查看其他分析師對這隻股票的看法。
  • Oppenheimer分析師Timothy Horan將阿卡邁科技公司(納斯達克:AKAM)的評級從表現升級至超越,宣佈$120的價格目標。阿卡邁科技股票週五收盤價爲$94.02。查看其他分析師對這隻股票的看法。
  • JP摩根分析師Matthew Boss將Gap公司(紐交所:GAP)的評級從中立升級至超重,並將價格目標從$28提高至$30。Gap股票週五收盤價爲$24.25。查看其他分析師對這隻股票的看法。
  • Evercore ISI Group分析師Vijay Kumar將NovoCure有限公司(納斯達克:NVCR)的評級從持平升級至超越,並將價格目標從$18提高至$30。NovoCure股票週五收盤價爲$20.04。查看其他分析師對這隻股票的看法。
  • TD Cowen分析師Bryan Bergin將Paycor HCm公司(納斯達克:PYCR)的評級從持有升級至買入,並將價格目標從$18提高至$22。Paycor HCm股票週二收盤價爲$18.06。查看其他分析師對這隻股票的看法。

Considering buying GAP stock? Here's what analysts think:

考慮購買GAP股票嗎?以下是分析師的看法:

big

Read This Next:

Read This Next:

  • How To Earn $500 A Month From Marvell Technology Stock Ahead Of Q3 Earnings
  • 如何在邁威爾科技股票的Q3盈利發佈之前每個月賺取500美元

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論